Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/27/2015 | US8940862 Selective anticancer chimeric peptides which bind transferrin receptor |
01/27/2015 | US8940857 Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
01/27/2015 | US8940732 Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway |
01/27/2015 | US8940713 Micro-RNA family that modulates fibrosis and uses thereof |
01/27/2015 | US8940712 Micro-RNA family that modulates fibrosis and uses thereof |
01/27/2015 | US8940711 Micro-RNA family that modulates fibrosis and uses thereof |
01/27/2015 | US8940709 Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules |
01/27/2015 | US8940708 Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF |
01/27/2015 | US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
01/27/2015 | US8940536 Methods for making somatic cells more susceptible to reprogramming |
01/27/2015 | US8940534 Immortalized avian cell lines for virus production |
01/27/2015 | US8940533 Mouse artificial chromosome vector |
01/27/2015 | US8940519 Method of producing a lipolytic enzyme |
01/27/2015 | US8940515 Polypeptides having xylanase activity and polynucleotides encoding same |
01/27/2015 | US8940514 Thioesterase and a method of producing fatty acids or lipids using the thioesterase |
01/27/2015 | US8940509 Microorganisms and methods for the production of caprolactone |
01/27/2015 | US8940504 Host cell protein knock-out cells for production of therapeutic proteins |
01/27/2015 | US8940502 Nucleic acid constructs and methods of making protein |
01/27/2015 | US8940479 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |
01/27/2015 | US8940310 Methods of treatment using TLR7 and/or TLR9 inhibitors |
01/27/2015 | US8940299 Method of treating cancer |
01/27/2015 | US8940296 Kits for segregating target nucleic acid from mixed nucleic acid samples |
01/27/2015 | US8940290 Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof |
01/27/2015 | US8940289 Fusion molecules and IL-15 variants |
01/27/2015 | US8939376 Encoding of microcarriers |
01/27/2015 | CA2842232C Systems and methods to perform assays for detecting or quantifying analytes within samples |
01/27/2015 | CA2733866C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
01/27/2015 | CA2705841C Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
01/27/2015 | CA2695264C Enrichment of a target sequence |
01/27/2015 | CA2632094C Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
01/27/2015 | CA2626423C Detection of primary infections with pathogens |
01/27/2015 | CA2610405C Mannitol induced promoter systems in bacterial host cells |
01/27/2015 | CA2603453C 5-fluorouracil-resistant bacteria and method for production thereof |
01/27/2015 | CA2597730C Peptides for detection of antibody to ehrlichia ewingii |
01/27/2015 | CA2575901C A method of treating cancer comprising a vegf-b antagonist |
01/27/2015 | CA2515699C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
01/27/2015 | CA2501653C Human anti-ifn-.gamma. neutralizing antibodies as selective ifn-.gamma. pathway inhibitors |
01/27/2015 | CA2488441C Synthetic antibody phage libraries |
01/27/2015 | CA2483285C Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
01/27/2015 | CA2480311C Oligomeric compounds for the modulation of hif-1alpha expression |
01/27/2015 | CA2470104C Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
01/27/2015 | CA2438133C Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
01/27/2015 | CA2298015C Production of erythropoietin by endogenous gene activation |
01/26/2015 | CA2857774A1 Variety corn line iq1883 |
01/26/2015 | CA2857771A1 Variety corn line gaq2011 |
01/26/2015 | CA2857768A1 Variety corn line id2516 |
01/26/2015 | CA2857767A1 Variety corn line hba2544 |
01/26/2015 | CA2857766A1 Variety corn line gna0098zl |
01/24/2015 | CA2857476A1 Variety corn line af3605 |
01/22/2015 | WO2015010114A1 Methods and compositions for producing double allele knock outs |
01/22/2015 | WO2015010075A1 Multiplex assay for the detection of at least two citrus pathogens |
01/22/2015 | WO2015010073A1 Attenuated influenza vaccines and uses thereof |
01/22/2015 | WO2015010030A1 Methods of improving titer in transfection-based production systems using eukaryotic cells |
01/22/2015 | WO2015010026A2 Compositions and methods for controlling leptinotarsa |
01/22/2015 | WO2015009952A1 Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
01/22/2015 | WO2015009853A1 Compositions for mucusal delivery, useful for treating papillomavirus infections |
01/22/2015 | WO2015009802A1 Methods and systems for utilizing sperm for molecular delivery |
01/22/2015 | WO2015009666A1 Suppression of silencing by gwar proteins |
01/22/2015 | WO2015008985A1 Detection of target nucleic acid sequence by pto cleavage and extension-dependent immobilized oligonucleotide hybridization |
01/22/2015 | WO2015008885A1 Method for diagnosing cervical cancer and diagnostic kit therefor |
01/22/2015 | WO2015008644A1 Method for adjusting expression of hydroxymethylglutaryl coa reductase using bzip-type transcription factor, isoprenoid-producing plant into which gene encoded for bzip-type transcription factor is introduced, and method for manufacturing polyisoprenoid in which said plant is used |
01/22/2015 | WO2015008637A1 Xanthine oxidase gene and amino acid sequence encoding same |
01/22/2015 | WO2015008508A1 Nucleic acid chromatography |
01/22/2015 | WO2015008320A1 Gene spatial distribution analysis system for cell tissue |
01/22/2015 | WO2015007871A2 Micrornas and autoimmune-immune mediated inflammatory disease |
01/22/2015 | WO2015007800A1 Method for extracting and purifying nucleic acids and buffers used |
01/22/2015 | WO2015007748A1 Diterpene production |
01/22/2015 | WO2015007536A2 Fusokines involving cytokines with strongly reduced receptor binding affinities |
01/22/2015 | WO2015007383A1 Solid phase transfection of proteins and nucleic acids |
01/22/2015 | WO2015007241A1 Molecular marker |
01/22/2015 | WO2015007240A1 Transgenic maize |
01/22/2015 | WO2015007216A1 Polypeptide, dna molecule encoding the polypeptide, vector, preparation method and use |
01/22/2015 | WO2015007194A1 Method for plant genome site-directed modification |
01/22/2015 | WO2015007033A1 Mutant of xylanase xynas9-m with improved thermal stability and gene and use thereof |
01/22/2015 | WO2015006864A1 Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles |
01/22/2015 | WO2014190273A9 Chimeric antigen receptor-targeting monoclonal antibodies |
01/22/2015 | US20150026845 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc |
01/22/2015 | US20150026844 Transgenic bioluminescent plants |
01/22/2015 | US20150026841 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof |
01/22/2015 | US20150026840 Constructs and systems and methods for producing microcompartments |
01/22/2015 | US20150026837 Soybean cultivar ua5612 |
01/22/2015 | US20150026835 Watermelon variety tcs-ej09137 |
01/22/2015 | US20150025232 Heptamer-type small guide nucleic acids inducing apoptosis of human leukemia cells |
01/22/2015 | US20150025231 Compositions and methods for modulation of ikbkap splicing |
01/22/2015 | US20150025228 Igg fc fragment for a drug carrier and method for the preparation thereof |
01/22/2015 | US20150025227 Igg fc fragment for a drug carrier and method for the preparation thereof |
01/22/2015 | US20150025127 Compositions and methods for inducing apoptosis |
01/22/2015 | US20150025124 Compositions and Methods for the Suppression of Target Polynucleotides from Lepidoptera |
01/22/2015 | US20150025122 Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro |
01/22/2015 | US20150025045 CBP AND p300-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS |
01/22/2015 | US20150025017 Compositions and methods for treating cancer |
01/22/2015 | US20150024990 Subtilase Variants |
01/22/2015 | US20150024971 Combined automated parallel synthesis of polynucleotide variants |
01/22/2015 | US20150024959 METHOD FOR AMPLIFYING cDNA DERIVED FROM TRACE AMOUNT OF SAMPLE |
01/22/2015 | US20150024957 Methods and Devices for Detection and Measurement of Analytes |
01/22/2015 | US20150024954 Aptamer regulated nucleic acids and uses thereof |
01/22/2015 | US20150024945 Systems and methods for sequencing in emulsion based microfluidics |
01/22/2015 | US20150024944 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
01/22/2015 | US20150024500 Methods and compositions for producing double allele knock outs |
01/22/2015 | US20150024499 Modified cascade ribonucleoproteins and uses thereof |